Methylprednisolone Completed Phase 3 Trials for Community Acquired Respiratory Disease Syndrome Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01283009Extended Steroid in CAP(e)